Nel ASA: Selected by Iberdrola as preferred supplier for a 20 MW green fertilizer project in Spain

OSLO, Norway, Nov. 4, 2020 — Nel Hydrogen Electrolyser, a division of Nel ASA (Nel, OSE:NEL), has been selected as preferred supplier by Iberdrola for a 20 MW PEM solution for a green fertilizer project in Spain. Contract award is subject to mutual agreement on the final commercial terms. The hydrogen…

GEN inCode Announces Completion of £3M Institutional Foundation Fundraise

OXFORD, England, Sept. 1, 2020 — GEN inCode UK Limited, the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease, announces today the completion of a £3.0M institutional fundraise to internationally scale its products and technology.    GEN inCode specializes in genetic risk assessment and the prediction…

G-ray Switzerland announces new CEO, closes successful funding round

NEUCHÂTEL, Switzerland, Aug. 31, 2020 — G-ray Switzerland, the medical imaging and industrial diagnosis start-up founded in 2014, has announced the appointment of Luis Pallares as Chief Executive Officer, as the company embarks on an accelerated growth drive and completes a successful funding round. Mr Pallares is focused on leading the transformation of…

Sai Life Sciences opens new, state-of-the-art Research & Technology Centre in Hyderabad

– Completes first phase in committed investment of US$ 150M (> INR 1000 Cr) – Sri KT Rama Rao, Hon’ble Minister for Industry & Commerce and IT, Government of Telangana inaugurates the facility HYDERABAD, India, Aug. 17, 2020 — Sai Life Sciences, one of…

K-BioMed Pioneer: VUNO Med®-Fundus AI™ Becomes Korea’s First-ever Innovative Medical Device

SEOUL, South Korea, July 27, 2020 — VUNO Inc., South Korean artificial intelligence (AI) developer and a member company of the Born2Global Centre, announced that VUNO Med®-Fundus AI™, its AI-based screening solution for the fundus, gained the honor of being the first-ever Innovative Medical Device in Korea by the Ministry of Food and Drug…

WuXi AppTec to Launch a Special Webinar on Collaborations that Transform on July 16 | Advances in Rare Diseases: Hemophilia

SHANGHAI and SAN DIEGO, July 9, 2020 — WuXi AppTec is pleased to announce that they are about to launch the second session of the webinar series "Collaborations That Transform," highlighting the impact of partnerships in bringing effective therapies to patients. This complimentary webinar, to be broadcast worldwide on July 16, will…

Paige Applauded by Frost & Sullivan for its Leading AI-based Computational Pathology Offering that Enables Fast and Accurate Cancer Diagnoses

Paige leveraged the world’s largest dataset in pathology to develop an unparalleled computation pathology offering SANTA CLARA, California, July 8, 2020 — Based on its recent analysis of the North American AI-based digital pathology market, Frost & Sullivan recognizes Paige with the 2020 North American Enabling Technology Leadership Award for…

TurtleTree Labs raises US$3.2 million seed round as it accelerates cell-based milk development

SINGAPORE, June 25, 2020 — Singapore-based biotech company TurtleTree Labs today announced the completion of a fresh round of funding from global investors. TurtleTree Labs is the world’s first-cell based biotechnology company creating real milk from mammalian cells, without the need for animals. As a platform, the company’s focus is…

VeChain and I-Dante Co-developed E-HCert, A Blockchain-based COVID-19 Records App For the Citizens of Cyprus

SHANGHAI, May 20, 2020 /PRNewswire/ — With the pandemic putting healthcare systems under strain worldwide, Electronic Health Record (EHR) systems are also shifting requirements for data security and sharing. As the leading public blockchain platform, VeChain furthers the collaboration with I-Dante to co-develop E-HCert App, which provides an archival solution for COVID-19 RT-PCR (real time-polymerase chain reaction) and antibodies tests (Rapid Test) records.


The success between VeChain and I-Dante previously on blockchain-enabled medical solution has led to the idea for the E-HCert App, which is now adopted by the Mediterranean Hospital of Cyprus. The new EHR system provides a secured method of on-chaining the COVID-19 related tests, giving the result of the health status of the individual, and allowing all concerning parties to access said health information at the discretion of the individual. With this set up, the individual can go about life as usual.

Compatible EHRs Should Compare Notes On The Pandemic

In the case of COVID-19, the testing results of citizens can be vital for public welfare and personal rights. Authorities worldwide are calling healthcare institutions to provide secure and legit access to health status information. Citizens themselves would also need trustworthy and reliable proof for their own health condition and full control over their privacy. However, current EHR systems are revealing serious deficiencies in terms of its interoperability, immutability, compliance, and the cost.

There is, therefore, an urgent need for the collection of trustworthy and standardized encrypted medical records that can be safely shared between multi parties.  This is where blockchain technology comes in and becomes the de facto choice for such an implementation.

The Most Feasible Choice For EHR reform: The Public Blockchain

This public blockchain-based E-HCert App provides an archival solution for COVID-19 RT-PCR (real time-polymerase chain reaction) and antibodies tests (Rapid Test) records, which will be utilized to enhance the hospital’s COVID-19 management and response at the end of May 2020.

When a Cyprus citizen goes to the hospital and undergoes RT-PCR and antibodies tests, the testing records will be uploaded onto the VeChainThor Blockchain, and the immutably recorded results are then shown in the E-HCert Native App.  As E-HCert fully complies with the GDPR, the App enables the owner to have complete control over their profiles, and use it to prove his or her health status when trying to return to work, take a flight abroad, and get authorized for other activities. 

Enabling The Next Wave Of Digital Health Reform

COVID-19 has prompted an expansion of industrial power in healthcare. A recent report found that 33 of the 50 US-based hospitals examined were working with Amazon, Google, or Microsoft. The Wall Street Journal said the internet giants are also wrestling for control in health-care  markets.

Compared with traditional technologies, blockchain provides better opportunities for companies to review their healthcare data systems, optimize the workflow design, while simultaneously enabling every patient to safely hold their records and share it immediately with any party in the world.

As the world’s leading public blockchain platform, VeChain intends to use its experience in the blockchain industry to empower more partners in the healthcare sector. By doing so, VeChain will play a central role in the acceleration of the digitalization of the healthcare industry.

About Mediterranean Hospital of Cyprus

The Mediterranean Hospital of Cyprus is a modern private health care institution, one of the largest in Cyprus, with a mission to provide to all the citizens and the visitors of the country safe and high-quality medical services 24/7. The founder of the Mediterranean Hospital of Cyprus, Dr. Andreas Panayiotou has set as a goal the development and the establishment of a reliable infirmary, with flexible operational mechanisms, in order to gain the trust and recognition for the quality of its services from everybody. Mediterranean Hospital of Cyprus is the first private hospital that joined Cyprus’ General HealthCare System (GHS).

Website: www.medihospital.com.cy/en/

About I-DANTE LTD

Founded in December of 2019 by Etna Digital Growth (a consultancy- software house company in Italy) and CircleServus LTD (a consultancy company in Cyprus) in order to build digital healthcare solutions leveraging the power of the VeChainThor Blockchain.

Website: www.i-dante.com/

About VeChain

Launched in 2015, VeChain connects blockchain technology to the real world by providing a comprehensive governance structure, a robust economic model, and IoT integration. VeChain is the pioneer of real-world applications using public blockchain technology, with international operations in Singapore, Luxembourg, Tokyo, Shanghai, Paris, Hong Kong, and San Francisco. Together with our strategic partners PwC and DNV GL, we have established cooperative relations with many leading enterprises in different industries, including Walmart China, BMW, BYDr, H&M, LVMH, D.I.G, ENN, AWS, PICC, ASI etc. Learn more about VeChain, please join the VeChain BootCamp.

Photo – https://techent.tv/wp-content/uploads/2020/05/vechain-and-i-dante-co-developed-e-hcert-a-blockchain-based-covid-19-records-app-for-the-citizens-of-cyprus.jpg
Logo – https://techent.tv/wp-content/uploads/2020/05/vechain-and-i-dante-co-developed-e-hcert-a-blockchain-based-covid-19-records-app-for-the-citizens-of-cyprus-1.jpg  

Berkeley Lights Launches Two New Capabilities in the Opto Cell Therapy Development 1.0 Workflow to Accelerate the Creation Of Effective Cancer Immunotherapies

The new multiplex cytokine and cytotoxicity assays as a part of the Opto Cell Therapy Development 1.0 workflow will help users of the Berkeley Lights’ platform develop cancer immunotherapies faster EMERYVILLE, Calif., April 28, 2020 /PRNewswire/ — Today, Berkeley Lights, Inc.,…